↓ Skip to main content

First-in-Class Small Molecule to Inhibit CYP11A1 And Steroid Hormone Biosynthesis

Overview of attention for article published in Molecular Cancer Therapeutics, September 2022
Altmetric Badge

Mentioned by

twitter
2 tweeters
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
First-in-Class Small Molecule to Inhibit CYP11A1 And Steroid Hormone Biosynthesis
Published in
Molecular Cancer Therapeutics, September 2022
DOI 10.1158/1535-7163.mct-22-0115
Pubmed ID
Authors

Mari Karimaa, Reetta Riikonen, Henna Kettunen, Päivi Taavitsainen, Meri Ramela, Marcin Chrusciel, Stefan Karlsson, Petteri Rummakko, Outi Simola, Gerd Wohlfahrt, Pasi Hakulinen, Annamari Vuorela, Heikki Joensuu, Tapio Utriainen, Karim Fizazi, Riikka Oksala

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 September 2022.
All research outputs
#18,039,847
of 22,311,486 outputs
Outputs from Molecular Cancer Therapeutics
#3,287
of 3,839 outputs
Outputs of similar age
#193,222
of 272,967 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#15
of 16 outputs
Altmetric has tracked 22,311,486 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,839 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one is in the 7th percentile – i.e., 7% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 272,967 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.